- Home
- NTIP vs ANTX Comparison
NTIP vs ANTX Comparison
Compare NTIP & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIP
- ANTX
- Stock Information
- Founded
- NTIP 1990
- ANTX 2017
- Country
- NTIP United States
- ANTX United States
- Employees
- NTIP N/A
- ANTX N/A
- Industry
- NTIP Multi-Sector Companies
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- NTIP Miscellaneous
- ANTX Health Care
- Exchange
- NTIP Nasdaq
- ANTX Nasdaq
- Market Cap
- NTIP 28.6M
- ANTX 33.2M
- IPO Year
- NTIP 1998
- ANTX 2022
- Fundamental
- Price
- NTIP $1.25
- ANTX $1.09
- Analyst Decision
- NTIP
- ANTX Buy
- Analyst Count
- NTIP 0
- ANTX 2
- Target Price
- NTIP N/A
- ANTX $2.00
- AVG Volume (30 Days)
- NTIP 13.9K
- ANTX 286.6K
- Earning Date
- NTIP 08-11-2025
- ANTX 08-12-2025
- Dividend Yield
- NTIP 8.00%
- ANTX N/A
- EPS Growth
- NTIP N/A
- ANTX N/A
- EPS
- NTIP N/A
- ANTX N/A
- Revenue
- NTIP $250,000.00
- ANTX N/A
- Revenue This Year
- NTIP N/A
- ANTX N/A
- Revenue Next Year
- NTIP N/A
- ANTX N/A
- P/E Ratio
- NTIP N/A
- ANTX N/A
- Revenue Growth
- NTIP N/A
- ANTX N/A
- 52 Week Low
- NTIP $1.16
- ANTX $0.87
- 52 Week High
- NTIP $1.78
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- NTIP 51.66
- ANTX 48.32
- Support Level
- NTIP $1.21
- ANTX $1.07
- Resistance Level
- NTIP $1.30
- ANTX $1.10
- Average True Range (ATR)
- NTIP 0.05
- ANTX 0.05
- MACD
- NTIP -0.00
- ANTX 0.00
- Stochastic Oscillator
- NTIP 64.29
- ANTX 35.71
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.